David Larsen
Stock Analyst at BTIG
(1.99)
# 3,095
Out of 5,106 analysts
93
Total ratings
35.14%
Success rate
-3.66%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Buy | $41 → $50 | $37.78 | +32.35% | 4 | Dec 23, 2025 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $19.33 | - | 4 | Dec 18, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.06 | +41.64% | 2 | Dec 12, 2025 | |
| PIII P3 Health Partners | Suspends: Neutral | n/a | $3.76 | - | 3 | Dec 12, 2025 | |
| AGL agilon health | Suspends: Neutral | n/a | $0.69 | - | 2 | Dec 12, 2025 | |
| HQY HealthEquity | Reiterates: Buy | $130 | $92.69 | +40.25% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $224.26 | +51.61% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $3.46 | +189.02% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $4.16 | +284.62% | 7 | Nov 7, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $45 | $24.44 | +84.12% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $34.80 | +144.25% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.38 | +107.10% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $9.74 | +54.00% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.35 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $43.53 | +83.78% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $25.57 | +9.50% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $22.74 | +36.32% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $225.15 | +15.48% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.52 | +177.78% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.88 | +695.36% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $45.57 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.73 | +47.49% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.21 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.56 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $207.37 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $825.73 | -80.62% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $76.50 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $78.04 | +8.92% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $2.66 | +764.66% | 1 | Nov 2, 2017 |
BrightSpring Health Services
Dec 23, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $37.78
Upside: +32.35%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $19.33
Upside: -
LifeStance Health Group
Dec 12, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.06
Upside: +41.64%
P3 Health Partners
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $3.76
Upside: -
agilon health
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $0.69
Upside: -
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $92.69
Upside: +40.25%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $224.26
Upside: +51.61%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.46
Upside: +189.02%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $4.16
Upside: +284.62%
Astrana Health
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $24.44
Upside: +84.12%
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $34.80
Upside: +144.25%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.38
Upside: +107.10%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.74
Upside: +54.00%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.35
Upside: -
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $43.53
Upside: +83.78%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $25.57
Upside: +9.50%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.74
Upside: +36.32%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $225.15
Upside: +15.48%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.52
Upside: +177.78%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.88
Upside: +695.36%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $45.57
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.73
Upside: +47.49%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.21
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.56
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $207.37
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $825.73
Upside: -80.62%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $76.50
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $78.04
Upside: +8.92%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $2.66
Upside: +764.66%